Home › Funds › Callodine Capital Management, LP › VTRS

Callodine Capital Management, LP position in VTRS

VIATRIS INC · Health Care

Callodine Capital Management, LP reported holding 8,302,927 shares of VTRS (VIATRIS INC) in its Q3 2026 13F filing — a position valued at US$147.1M, representing 9.43% of its reported portfolio and ranking #1 among its reported holdings. Callodine Capital Management, LP has disclosed VTRS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)8.30M sh
Reported value held$147.13M
Portfolio Weight9.43%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Callodine Capital Management, LP's VTRS position evolved

Callodine Capital Management, LP first disclosed a stake in VTRS in Q3 2023 at 2,320,000 shares (US$22.9M). The position peaked in Q3 2026 at 8,302,927 shares, worth US$147.1M. Across 13 filings, Callodine Capital Management, LP increased the stake 9 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 8,302,927 shares valued at US$147.1M — an increase of 302,185 shares quarter over quarter.. Notable position changes include a 31% increase in Q1 2025 (shares rose 3% over the following quarter), a 65% increase in Q2 2025 (shares rose 11% over the following quarter), a 39% increase in Q4 2025 (shares rose 9% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.32M $22.88M New
Q4 2023 2.52M $27.29M Add
Q1 2024 2.30M $27.46M Reduce
Q2 2024 2.54M $27.02M Add
Q3 2024 2.69M $31.20M Add
Q4 2024 2.77M $34.55M Add
Q1 2025 3.62M $31.57M Add
Q2 2025 6.00M $53.54M Add
Q3 2025 6.94M $68.72M Add
Q4 2025 9.68M $120.53M Add
Q1 2026 8.12M $109.68M Reduce
Q2 2026 8.00M $127.05M Reduce
Q3 2026 8.30M $147.13M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VTRS and 13F data

VTRS (VIATRIS INC) is a Health Care company. 32 other funds we track also report a position in VTRS — the largest reported positions include DAVIS SELECTED ADVISERS (US$1.28B), Rubric Capital Management LP (US$542.6M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$320.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VTRS

All VTRS fund holders →

FAQ

How long has Callodine Capital Management, LP held VTRS?

Callodine Capital Management, LP has disclosed VTRS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Callodine Capital Management, LP's current position in VTRS?

As of Q3 2026, Callodine Capital Management, LP holds 8.30M shares of VTRS (VIATRIS INC), valued at $147.13M, representing 9.43% of its reported portfolio and ranking #1.

Has Callodine Capital Management, LP been buying or selling VTRS?

In the latest 13F filing (Q3 2026), Callodine Capital Management, LP increased its position in VTRS. The position peaked in Q3 2026 at 8.30M shares.

Which other funds hold VTRS?

Other major institutional holders of VTRS include DAVIS SELECTED ADVISERS, Rubric Capital Management LP, DEERFIELD MANAGEMENT COMPANY, L.P., among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.